A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin & cefixime examined by observational cohort studies

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
Comparison_thumbnail
Detail Image
Comparison_mobile
Book Detail
Upload PDF
ACOMPA~1.PDF (211.85 KB)
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

A Prescription-Event Monitoring study compared the safety of three 4-quinolones—ciprofloxacin, norfloxacin, and ofloxacin—with azithromycin and cefixime during early post-marketing use. All five antibiotics were found to be acceptably safe for routine clinical practice. The study also highlighted PEM as an effective method for monitoring the safety of new antimicrobial agents.

Published Date